164 related articles for article (PubMed ID: 23165319)
1. Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.
Szepes M; Janicsek Z; Benkő Z; Cselenyák A; Kiss L
Int J Mol Med; 2013 Jan; 31(1):26-32. PubMed ID: 23165319
[TBL] [Abstract][Full Text] [Related]
2. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
[TBL] [Abstract][Full Text] [Related]
3. A novel and orally active poly(ADP-ribose) polymerase inhibitor, KR-33889 [2-[methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1H-benzimidazole-4-carboxylic acid amide], attenuates injury in in vitro model of cell death and in vivo model of cardiac ischemia.
Oh KS; Lee S; Yi KY; Seo HW; Koo HN; Lee BH
J Pharmacol Exp Ther; 2009 Jan; 328(1):10-8. PubMed ID: 18836068
[TBL] [Abstract][Full Text] [Related]
4. Poly-ADP-ribose-polymerase inhibition ameliorates hind limb ischemia reperfusion injury in a murine model of type 2 diabetes.
Long CA; Boulom V; Albadawi H; Tsai S; Yoo HJ; Oklu R; Goldman MH; Watkins MT
Ann Surg; 2013 Dec; 258(6):1087-95. PubMed ID: 23549425
[TBL] [Abstract][Full Text] [Related]
5. PARP inhibitor PJ34 ameliorates cognitive impairments induced by transient cerebral ischemia/reperfusion through its anti-inflammatory effects in a rat model.
Jiao Y; Li G
Neurosci Lett; 2021 Nov; 764():136202. PubMed ID: 34478817
[TBL] [Abstract][Full Text] [Related]
6. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribose) Polymerase (PARP) is Critically Involved in Liver Ischemia/Reperfusion-injury.
Haga S; Kanno A; Morita N; Jin S; Matoba K; Ozawa T; Ozaki M
J Surg Res; 2022 Feb; 270():124-138. PubMed ID: 34656890
[TBL] [Abstract][Full Text] [Related]
8. Novel phenanthridinone inhibitors of poly (adenosine 5'-diphosphate-ribose) synthetase: potent cytoprotective and antishock agents.
Jagtap P; Soriano FG; Virág L; Liaudet L; Mabley J; Szabó E; Haskó G; Marton A; Lorigados CB; Gallyas F; Sümegi B; Hoyt DG; Baloglu E; VanDuzer J; Salzman AL; Southan GJ; Szabó C
Crit Care Med; 2002 May; 30(5):1071-82. PubMed ID: 12006805
[TBL] [Abstract][Full Text] [Related]
9. [Role of poly(ADP-ribose) polymerases-1-mediated blockade of autophagy in ischemia/reperfusion injury of rat cardiomyocytes].
Zhao W; Wang Y; Wei G; Xu S
Nan Fang Yi Ke Da Xue Xue Bao; 2018 Jul; 38(8):975-979. PubMed ID: 30187876
[TBL] [Abstract][Full Text] [Related]
10. Intervention timing and effect of PJ34 on astrocytes during oxygen-glucose deprivation/reperfusion and cell death pathways.
Cai C; Zhang R; Huang QY; Cao X; Zou LY; Chu XF
J Huazhong Univ Sci Technolog Med Sci; 2015 Jun; 35(3):397-404. PubMed ID: 26072080
[TBL] [Abstract][Full Text] [Related]
11. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
[TBL] [Abstract][Full Text] [Related]
12. Poly-ADP-ribose polymerase inhibition enhances ischemic and diabetic wound healing by promoting angiogenesis.
Zhou X; Patel D; Sen S; Shanmugam V; Sidawy A; Mishra L; Nguyen BN
J Vasc Surg; 2017 Apr; 65(4):1161-1169. PubMed ID: 27288104
[TBL] [Abstract][Full Text] [Related]
13. The poly(adenosine diphosphate-ribose) polymerase inhibitor PJ34 reduces pulmonary ischemia-reperfusion injury in rats.
Hatachi G; Tsuchiya T; Miyazaki T; Matsumoto K; Yamasaki N; Okita N; Nanashima A; Higami Y; Nagayasu T
Transplantation; 2014 Sep; 98(6):618-24. PubMed ID: 25221900
[TBL] [Abstract][Full Text] [Related]
14. Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.
Szabó G; Bährle S; Stumpf N; Sonnenberg K; Szabó E E; Pacher P; Csont T; Schulz R; Dengler TJ; Liaudet L; Jagtap PG; Southan GJ; Vahl CF; Hagl S; Szabó C
Circ Res; 2002 Jan; 90(1):100-6. PubMed ID: 11786525
[TBL] [Abstract][Full Text] [Related]
15. Myocardial protection by PJ34, a novel potent poly (ADP-ribose) synthetase inhibitor.
Faro R; Toyoda Y; McCully JD; Jagtap P; Szabo E; Virag L; Bianchi C; Levitsky S; Szabo C; Sellke FW
Ann Thorac Surg; 2002 Feb; 73(2):575-81. PubMed ID: 11845877
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts.
Fiorillo C; Ponziani V; Giannini L; Cecchi C; Celli A; Nassi N; Lanzilao L; Caporale R; Nassi P
Cell Mol Life Sci; 2006 Dec; 63(24):3061-71. PubMed ID: 17131054
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of poly(ADP-Ribose) polymerase enhances the toxicity of 131I-metaiodobenzylguanidine/topotecan combination therapy to cells and xenografts that express the noradrenaline transporter.
McCluskey AG; Mairs RJ; Tesson M; Pimlott SL; Babich JW; Gaze MN; Champion S; Boyd M
J Nucl Med; 2012 Jul; 53(7):1146-54. PubMed ID: 22689924
[TBL] [Abstract][Full Text] [Related]
18. 3-Aminobenzamide protects primary human keratinocytes from UV-induced cell death by a poly(ADP-ribosyl)ation independent mechanism.
Lakatos P; Szabó É; Hegedűs C; Haskó G; Gergely P; Bai P; Virág L
Biochim Biophys Acta; 2013 Mar; 1833(3):743-51. PubMed ID: 23246565
[TBL] [Abstract][Full Text] [Related]
19. Postischemic poly (ADP-ribose) polymerase (PARP) inhibition reduces ischemia reperfusion injury in a hind-limb ischemia model.
Crawford RS; Albadawi H; Atkins MD; Jones JE; Yoo HJ; Conrad MF; Austen WG; Watkins MT
Surgery; 2010 Jul; 148(1):110-8. PubMed ID: 20132957
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of proliferation and invasiveness of ovarian cancer C13* cells by a poly(ADP-ribose) polymerase inhibitor and the role of nuclear factor-κB.
Wang Z; Li Y; Lv S; Tian Y
J Int Med Res; 2013 Oct; 41(5):1577-85. PubMed ID: 24097829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
